env Gene Products, Human Immunodeficiency Virus
"env Gene Products, Human Immunodeficiency Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins encoded by the ENV GENE of the HUMAN IMMUNODEFICIENCY VIRUS.
MeSH Number(s)
D12.776.964.775.325.164
D12.776.964.775.562.500
D12.776.964.970.880.325.164
Below are MeSH descriptors whose meaning is more general than "env Gene Products, Human Immunodeficiency Virus".
Below are MeSH descriptors whose meaning is more specific than "env Gene Products, Human Immunodeficiency Virus".
This graph shows the total number of publications written about "env Gene Products, Human Immunodeficiency Virus" by people in Harvard Catalyst Profiles by year, and whether "env Gene Products, Human Immunodeficiency Virus" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2004 | 0 | 2 | 2 |
2005 | 0 | 3 | 3 |
2006 | 0 | 1 | 1 |
2007 | 1 | 1 | 2 |
2008 | 1 | 6 | 7 |
2009 | 5 | 3 | 8 |
2010 | 4 | 2 | 6 |
2011 | 9 | 5 | 14 |
2012 | 5 | 7 | 12 |
2013 | 9 | 7 | 16 |
2014 | 13 | 8 | 21 |
2015 | 7 | 7 | 14 |
2016 | 10 | 2 | 12 |
2017 | 8 | 10 | 18 |
2018 | 11 | 6 | 17 |
2019 | 17 | 9 | 26 |
2020 | 12 | 6 | 18 |
2021 | 8 | 4 | 12 |
2022 | 0 | 1 | 1 |
Below are the most recent publications written about "env Gene Products, Human Immunodeficiency Virus" by people in Profiles.
-
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice. Cell Rep. 2022 03 15; 38(11):110514.
-
Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial. J Clin Invest. 2021 12 01; 131(23).
-
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env. Sci Transl Med. 2021 11 24; 13(621):eabk1533.
-
SOSIP Trimer-Specific Antibodies Isolated from a Simian-Human Immunodeficiency Virus-Infected Monkey with versus without a Pre-blocking Step with gp41. J Virol. 2022 01 26; 96(2):e0158221.
-
Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer. J Virol. 2021 11 23; 95(24):e0052921.
-
A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination. Cell Rep Med. 2021 09 21; 2(9):100386.
-
Oral Vaccination Approaches for Anti-SHIV Immunity. Front Immunol. 2021; 12:702705.
-
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates. PLoS Pathog. 2021 06; 17(6):e1009624.
-
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. Cell. 2021 05 27; 184(11):2955-2972.e25.
-
Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir. Cell Host Microbe. 2021 Jun 09; 29(6):904-916.e6.